Presentation to feature results from first clinical study of ART26.12 and highlight the potential of

Gainers Firefly Neuroscience (NASDAQ:AIFF) shares increased by 33.2% to $1.58 during Friday's r

Gainers Apimeds Pharmaceuticals (AMEX:APUS) shares increased by 162.4% to $6.01 during Thursday&#39

U.S. stocks fell Thursday as tech slid; jobless claims beat estimates. Oil rose, while APUS surged 2

Gainers Profusa (NASDAQ:PFSA) stock increased by 112.5% to $4.36 during Thursday's pre-market s

GlucoTrack surged 117.7% premarket after Lokahi Therapeutics signed its first external partnership;

Gainers GlucoTrack (NASDAQ:GCTK) stock moved upwards by 90.6% to $3.87 during Wednesday's after

Artelo Biosciences, Inc. (NASDAQ: ARTL) shares are surging Wednesday afternoon after the clinical-st

Gainers Artelo Biosciences (NASDAQ:ARTL) shares rose 216.1% to $13.12 during Wednesday's regula

As reported, ART27.13 produced approximately 40% weight loss in combination with semaglutide and app

Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 354.9% to $7.37 during Wednesday's regula

Artelo Biosciences shares new nonclinical data showing its oral cannabinoid drug ART27.13 matches se

Gainers DataMEDS AI (NASDAQ:MEDS) shares rose 124.1% to $3.63 during Wednesday's pre-market ses

Gainers Immuron (NASDAQ:IMRN) stock increased by 64.9% to $1.83 during Friday's pre-market sess

Artelo Biosciences, Inc. (NASDAQ:ARTL) ("Artelo" or the "Company"), a clinical-stage

Artelo Biosciences, Inc. (Nasdaq: ARTL) ("Artelo" or the "Company"), a clinical-stag

The Patent Claims are for the Intended Commercial Formulation of ART27.13Expected to Extend Patent P

Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(0.89) per share. This is a 94.71 per

Investigator-led study funded by Glaucoma UK and the HSC R&D Division expands ART27.13’s clinica

The peer-reviewed evaluation analyzed the efficacy, pharmacokinetics, and safety data obtained from

Artelo Biosciences, Inc. (Nasdaq: ARTL) ("Artelo" or the "Company"), a clinical-stag

Gainers Agape ATP (NASDAQ:ATPC) shares rose 17.5% to $2.96 during Wednesday's after-market sess

Expands potential benefit for treating neuropathic pain in cancer patients, particularly those exper

Artelo Biosciences, Inc. (Nasdaq: ARTL) ("Artelo" or the "Company"), a clinical-stag

Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulati

The presentations include results from the Phase 1 clinical study of ART26.12 as well as new biomark

Artelo Biosciences, Inc. (NASDAQ:ARTL) ("Artelo" or the "Company"), a clinical-stage

U.S. stocks traded mixed, Nasdaq down 0.3%. Dow up 0.59%, S&P 500 down 0.09%. Consumer discretio

US stocks mixed, Dow up 300 pts. Dow up 0.64%, NASDAQ down 0.34%. Consumer discretionary up 1.7%, en

Semtech Corp (SMTC) reported strong Q1 financial results, beating analysts' estimates. Shares ro

Gainers: PHGE +97.3%, ARTL +74.8%, QTEX +52.4%, MNTX +34.4%, HLIT +28.3%, WOK +25%, CPSH +24.7%, COD

Liveramp Holdings Inc (NYSE: RAMP) rose in pre-market trading after being acquired by Publicis for $

Artelo Biosciences (NASDAQ:ARTL) reported quarterly losses of $(4.00) per share which missed the ana

https://www.sec.gov/Archives/edgar/data/1621221/000164033426000820/artl_s3.htm

Artelo Biosciences, Inc. (NASDAQ:ARTL), a clinical-stage pharmaceutical company focused on modulatin

Artelo Biosciences, Inc. (NASDAQ:ARTL) shares jumped on Monday after the company announced the publi

Demonstrates ART26.12's Differentiated Profile as a Promising Pain Treatment Ahead of Planned Mu

A look at the most-searched tickers on Benzinga Pro for the month of March shows several newcomers a

Virgin Galactic reported Q4 revenue of $312,000, missing estimates, but beat EPS expectations. Its s

U.S. stock futures up, Dow gains 150 points. Avis Budget Group (CAR) shares fall 9.6% in pre-market.

PMGC Holdings shares surged 100.6% to $3.35 in pre-market trading after announcing a licensing agree